Supercharge Your Innovation With Domain-Expert AI Agents!

Novel compounds and their use in treatment of autoimmune diseases

A compound and free technology, applied in the direction of allergic diseases, metabolic diseases, skin diseases, etc., can solve the problems of destroying normal tissues, and the immune system cannot distinguish harmful antigens in body organs, so as to restore immune balance and damaged tissues, prevent and treat diseases The effect of treating autoimmune diseases

Pending Publication Date: 2022-05-27
PARENCHYMA BIOTECH INC
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

If an autoimmune condition is present, the immune system cannot distinguish its body organs from harmful antigens and may destroy normal tissue

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel compounds and their use in treatment of autoimmune diseases
  • Novel compounds and their use in treatment of autoimmune diseases
  • Novel compounds and their use in treatment of autoimmune diseases

Examples

Experimental program
Comparison scheme
Effect test

preparation example

[0183] 1. Synthesis of N-(5-bromo-6-methylpyridin-2-yl)-2-(5-chloro-1H-indol-3-yl)acetamide (compound 8)

[0184] [Process 1]

[0185]

[0186] Stir 2-(5-chloro-1H-indol-3-yl)acetic acid (1.00 g, 4.77 mmol) in CH at room temperature 2 Cl 2 (30 mL), 5-bromo-6-methylpyridin-2-amine (892 mg, 4.77 mmol), 1-[bis(dimethylamino)methylene]-1H-1 were added dropwise in this order. , 2,3-triazo[4,5-b]pyridinium-3-oxide hexafluorophosphate (HATU, 2.18 g, 5.72 mmol) and trimethylamine (1.33 mL, 9.54 mmol). The reaction mixture was stirred at room temperature for 3 days, and distilled water (10 mL) was added to the mixture to terminate the reaction. The layers were separated, and the organic layer was washed with distilled water, washed with anhydrous Na 2 SO 4 Dry and filter. After the filtrate was concentrated under reduced pressure, the concentrate was subjected to column chromatography (SiO 2 , Hexane:EtOAc = 4:1-2:1) was purified to give the light grey compound (970 mg, 54%)....

Embodiment

[0338] Example: Measurement of the activity of compounds - experimental protocol

[0339] 1. Compound Search and Preparation

[0340] In order to confirm the target specificity of the prepared compound, evaluation was performed by the following method.

[0341] After recovering HepG2 cultured in DMEM-fetal bovine serum (FBS) 10% medium and confirming the viability of 97% or more by trypan blue staining, the recovered product was centrifuged at 1200 rpm for 5 minutes at room temperature, and by dividing the cells by 3 × 10 5 Cells / ml were prepared by resuspending in DMEM-fetal bovine serum 10% medium. Thereafter, cells were aliquoted at 3 mL into 60 mm dishes, and each dish was treated with 50 μl of compound at a concentration of 5 μM diluted in DMEM medium, and then incubated in a cell incubator (5% CO 2 incubator) for 24 hours. As a control, 50 μl of 0.05% dimethyl sulfoxide (DMSO) / DMEM medium was used for treatment.

[0342] The cultured cells were recovered to prepar...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a novel compound and application thereof in treatment of autoimmune diseases. The pharmaceutical composition for treating or preventing autoimmune diseases, comprising the novel compound of the present invention, not only can control inflammation, but also can repair tissue homeostasis by repairing immune balance and damaged tissue, thereby having an excellent effect of treating and preventing autoimmune diseases, and furthermore, the pharmaceutical composition can be used for treating or preventing autoimmune diseases. The composition has excellent effects of treating and preventing cancers.

Description

technical field [0001] The present invention relates to novel compounds and their use for the treatment of autoimmune diseases. Background technique [0002] The body can be protected from pathogens through an immune response. Biological defense mechanisms against foreign microorganisms such as viruses and bacteria are generally classified into innate immunity and specific immunity, which are mediated by cytokines mainly secreted by immune-related cells. [0003] The immune system serves to protect the body from antigens (ie, harmful foreign substances). Types of these antigens include bacteria, viruses, toxins, cancer cells, and blood and tissues from other humans or animals. The immune system produces antibodies to destroy these harmful substances. If an autoimmune disorder is present, the immune system cannot distinguish between its body organs and harmful antigens, and normal tissue may be destroyed. Diseases induced by such responses as described above are autoimmun...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/12C07D417/12C07D209/18A61K31/4439A61K31/428A61K31/4709A61K31/405A61P1/00A61P29/00A61P37/06A61P11/06A61P17/06A61P19/02A61P3/10A61P25/28A61P35/00A61P35/02
CPCC07D401/12C07D417/12C07D209/18A61P1/00A61P29/00A61P37/06A61P11/06A61P17/06A61P19/02A61P3/10A61P25/28A61P35/00A61P35/02A61P37/00C07D403/12A61K31/4439A61K31/428
Inventor 徐守吉张元熙李星旻尹恩惠朴河映金彩恩
Owner PARENCHYMA BIOTECH INC
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More